Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8586553
Therapies for cancer using RLIP76
granted -
US 8580845
Functionalized expanded porphyrins
granted -
US 8580738
Methods for treatment of reperfusion injury and other cardiac conditions
granted -
US 8562993
Methods for treating GI syndrome and graft versus host disease
granted -
US 8563595
Treatment of cancer with complex organic-inorganic pigment compositions
granted -
US 8563022
Particles for cell targeting
granted -
US 8551526
Preparation of drug particles using evaporation precipitation into aqueous solutions
granted -
US 8551997
Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
granted -
US 8546348
Upregulation of opioid receptors for management
granted -
US 8546371
Nanoparticle formulated glycolipid antigens for immunotherapy
granted -
US 8530516
Promoting cycling of ApoE4 isoform
granted -
US 8529916
High concentration baclofen preparations
granted -
US 8529872
Seeds and markers for use in imaging
granted -
US 8530245
Methods and compositions related to acetylocholine receptor conjugates
granted -
US 8513209
Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair
granted -
US 8507445
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
granted -
US 8501705
Methods and materials for treating autoimmune and/or complement mediated diseases and conditions
granted -
US 8501423
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
granted -
US 8501740
Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors
granted -
US 8486391
Cancer treatment kits using antibodies to aminophospholipids
granted -
US 8486428
Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles
granted -
US 8486410
RLIP76 liposomes for protection against irradiation
granted -
US 8486423
Thermo-kinetic mixing for pharmaceutical applications
granted -
US 8481507
Micro-RNAs that control myosin expression and myofiber identity
granted